Management of non-vitamin K antagonist oral anticoagulants in perioperative and emergency settings requires a multimodal approach, including prothrombin complex concentrates for life-threatening bleeding, due to the current lack of specific antidotes.
No takes yet. Share an insight, caveat, or question.
Highlights ongoing NOAC management challenges; leaves open targeted antidote development and validation trials.
Faraoni et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: